GeoVax to Participate in Upcoming Investor Conferences in September
GeoVax Labs, Inc. (GOVX)
NASDAQ:AMEX Investor Relations:
geovax.com/contact-geovax.html
Company Research
Source: GlobeNewswire
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chairman and CEO, David Dodd, will present at two upcoming investor events: H.C. Wainwright 26th Annual Global Investment Conference Speaker: David Dodd, Chairman & CEO Date/Time: September 9, 2024 at 7:00 a.m. ET Location: Lotte New York Palace Hotel, New York, NY Webcast Link: H.C. Wainwright Webcast Title: GeoVax Corporate Update Senior GeoVax management will host one-on-one meetings with registered attendees. If interested in meeting with management at this event, please contact the company through the conference portal, or directly at info@geovax.com. Emerging Growth Conference Speaker: David Dodd, Chairman & CEO Date/Time: September 25, 2024 at 2:55 p.m. ET Location: Virtual Webcast Link: Emerging Growth Conference Webcas
Show less
Read more
Impact Snapshot
Event Time:
GOVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GOVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GOVX alerts
High impacting GeoVax Labs, Inc. news events
Weekly update
A roundup of the hottest topics
GOVX
News
- GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia [Yahoo! Finance]Yahoo! Finance
- GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic LeukemiaGlobeNewswire
- GeoVax Labs, Inc. (NASDAQ: GOVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.MarketBeat
- Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges [Yahoo! Finance]Yahoo! Finance
- GeoVax Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
GOVX
Earnings
- 11/12/24 - Beat
GOVX
Analyst Actions
- 11/15/24 - HC Wainwright
GOVX
Sec Filings
- 11/18/24 - Form 8-K
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- GOVX's page on the SEC website